Ticlopidine-induced aplastic anemia and quick recovery with G-CSF: Case report and literature review

American Journal of Hematology

Volumn 63, Issue 2, 2000, Pages 90-93

  Taher, A ^a   Ammash, Z ^a   Dabajah, B ^a   Nasrallah, A ^a   Mourad, F H ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Aplastic anemia; G CSF; Ticlopidine

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; TICLOPIDINE;

AGED; APLASTIC ANEMIA; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HUMAN; LEUKOCYTE COUNT; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; ASPIRIN; BONE MARROW CELLS; CORONARY DISEASE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; TICLOPIDINE;

EID: 0033959517     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(200002)63:2<90::AID-AJH6>3.0.CO;2-W     Document Type: Article

References (24)

1. Harker LA, Bruno JJ. Ticlopidine's mechanism of action on human platelets. In: Hass WK, Easton JD, eds. Ticlopidine, platelets and vascular disease. New York: Springer-Verlag; 1993. p 41-59.
2. Molony BA. An analysis of the side-effects of ticlopidine. In: Hass WK, Easton JD, eds. Ticlopidine, platelets and vascular disease. New York: Springer-Verlag; 1993; p 117-139.
3. Gent M, Easton JD, Hashinski VC, Panak EA, Sicurella J, Blakely JA. et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;1:1215-1220.
4. Garnier G, Taillan B, Pesce A, Chichmanian RM, Dujardin P. Ticlopidine and severe aplastic anemia (letter). Br J Haematol 1992;81:459-460.
5. Troussard X, Mayo P, Mosquet B, Reman O, Leporrier M. Ticlopidine and severe aplastic anemia (letter). Br J Haematol 1992;82:779-780.
6. Khelif A, Assouline D, Ffrench M, Chaumentin G, Viala JJ. Ticlopidine and aplastic anemia (letter). Br J Haematol 1993;83:678-679.
7. Mallet L, Mallet J. Ticlopidine and fatal aplastic anemia in an elderly woman. Ann Pharmacother 1994;28:1169-1171.
8. Rodriguez JN, Fernandez-Jurado A, Dieguez JC, Amian A, Prados D. Ticlopidine and severe aplastic anemia (letter). Am J Hematol 1994; 47:332.
9. Lesesve JF, Callat MP, Lenormand B, Monconduit M, Noblet C. Moore N, et al. Hematological toxicity of ticlopidine (letter). Am J Hematol 1994;47:149-150.
10. Su CC, Tseng CD, Hwang JJ, Tien HF, Lee YT. Severe aplastic anemia induced by ticlopidine: report of a case. J Formosan Med Assoc 1995;94:689-691.
11. Arribalzaga K, Garcia-Suarez J, Lopez-Rubio M, Krsnik I, Calero MA, Del-Campo JF. Sustained granulocyte recovery after G-CSF in a patient with ticlopidine-induced severe aplastic anemia (letter). Am J Hematol 1995;50:313.
12. Dunn P. Aplastic anemia with ticlopidine therapy in two chinese patients (letter). Ann Pharmacother 1996;30:547.
13. Shapiro CM, Walk D. Aplastic anemia associated with ticlopidine. Neurology 1996;47:300.
14. Green D. CAPRIE trial. Lancet 1997;349:354-355.
15. Elias M, Reichman N, Flatau E. Bone marrow aplasia associated with ticlopidine therapy. Am J Hematol 1993;44:289-291.
16. Carlston JA, Maesner JE. Fatal neutropenia and thrombocytopenia associated with ticlopidine. Ann Pharmacother 1994;28:1236-1237.
17. Martin-Nunez G, Fernandez-Soria RR, Sanchez-Gil F, Benitez-Cano E. Aplastic anemia and ticlopidine (letter). Br J Haematol 1993;85: 633.
18. Mataix R, Ojeda E, Perez MC, Jimenez S. Ticlopidine and severe aplastic anemia. Br J Haematol 1992;80:125-126.
19. Weiner P, Zidan F, Paz R. Severe aplastic anemia due to ticlopidine. Isr J Med Sci 1995;31:444-445.
20. Syntex Laboratories. Ticlid (ticlopidine) package insert. Palo Alto, CA; 1992.
21. Ono K, Kurohara K, Yoshihara M, Shimamoto Y, Yamaguchi M. Agranulocytosis caused by ticlopidine and its mechanism. Am J Hematol 1991;37:239-242.
22. Yunis A, Armimura G, Lo L. Ticlopidine: Quo vadis? Comparative effect of ticlopidine and analogues on in vitro myeloid colony (CFU-GM) growth. Agent Action 1984;15(Suppl):136.
23. Resegotti L, Pistone MA, Testa D. Culture de moelle chez les sujets traites par la ticlopidine. Nouv Rev Fr Hematol 1985;27:19-22.
24. Guericiolini R, Giiodano G, Aversa F, Del Favero A. Anemia and agranulocytosis associated with ticlopidine therapy. Acta Haematol (Basel) 1985;73:232.